|
Leukemia, Acute Myeloid, Adult
|
|
Acute Myeloid Leukemia; Acute Myeloid Leukemia, Adult; Acute Myeloid Leukemia, Childhood; Adult Acute Myeloid Leukemia; Myeloid Leukemia, Adult Acute
|
Leukemia, Acute Myeloid, Adult Clinical Trials
- Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00002719 - Active, not recruiting
adult acute myelomonocytic leukemia (M4); untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
- Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00006122 - Active, not recruiting
untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
- Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00096122 - Active, not recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; ...
- Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission
ClinicalTrials.gov Identifier: NCT00002768 - Active, not recruiting
adult acute differentiated monocytic leukemia (M5b); adult acute myeloblastic leukemia without maturation (M1); ...
- Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002549 - Active, not recruiting
adult acute myelomonocytic leukemia (M4); untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
- Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00017342 - Active, not recruiting
recurrent adult acute myeloid leukemia; adult acute myeloid leukemia with t(8;21)(q22;q22); adult acute myeloid leukemia with t(16;16)(p13;q22); ...
- Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00112853 - Active, not recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
- PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00004217 - Active, not recruiting
untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
- Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00003190 - Active, not recruiting
untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
- Cytarabine and Daunorubicin with Or Without Gemtuzumab Ozogamicin in Treating Older Patients with Acute Myeloid Leukemia Or Myelodysplastic Syndromes
ClinicalTrials.gov Identifier: NCT00121303 - Active, not recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; ...
- Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00006045 - Active, not recruiting
adult acute differentiated monocytic leukemia (M5b); adult acute myeloblastic leukemia without maturation (M1); ...
- Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00039117 - Active, not recruiting
untreated adult acute myeloid leukemia; secondary acute myeloid leukemia; adult acute myeloid leukemia with t(8;21)(q22;q22); ...
- Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00006084 - Active, not recruiting
adult acute differentiated monocytic leukemia (M5b); adult acute myeloblastic leukemia without maturation (M1); ...
- Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission
ClinicalTrials.gov Identifier: NCT00002534 - Active, not recruiting
childhood acute myeloid leukemia in remission; adult acute lymphoblastic leukemia in remission; recurrent adult acute myeloid leukemia; ...
- Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00093418 - Active, not recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
- Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002925 - Active, not recruiting
untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
- GTI-2040 and High-Dose Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00070551 - Active, not recruiting
recurrent adult acute myeloid leukemia; adult acute myeloid leukemia with t(8;21)(q22;q22); adult acute myeloid leukemia with t(16;16)(p13;q22); ...
- Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse
ClinicalTrials.gov Identifier: NCT00002554 - Active, not recruiting
recurrent adult acute myeloid leukemia; adult acute myeloid leukemia in remission
- High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00002945 - Active, not recruiting
adult acute myelomonocytic leukemia (M4); untreated adult acute myeloid leukemia; adult acute monocytic leukemia (M5); ...
- Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00004215 - Active, not recruiting
Anemia; adult acute poorly differentiated monocytic leukemia (M5a); adult acute myeloblastic leukemia with maturation (M2); ...
- PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00093600 - Active, not recruiting
adult acute myeloid leukemia with 11q23 (MLL) abnormalities; adult acute myeloid leukemia with inv(16)(p13;q22); ...
- Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00005801 - Active, not recruiting
adult acute differentiated monocytic leukemia (M5b); adult acute myeloblastic leukemia without maturation (M1); ...
- Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00101296 - Recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
- Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00091234 - Active, not recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
- Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00003758 - Active, not recruiting
acute leukemia; childhood cancer; hematopoietic/lymphoid cancer; Cancer; Leukemia; cellular diagnosis, childhood acute myeloid leukemia; ...
- Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00066794 - Active, not recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
- Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00052299 - Active, not recruiting
adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
- Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00005802 - Active, not recruiting
adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; childhood acute myeloid leukemia
- Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00027872 - Active, not recruiting
adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
- Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00048958 - Recruiting
adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; ...
- Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00005795 - Completed
untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
- Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00093483 - Recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
- Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00124644 - Recruiting
adult acute myeloid leukemia with 11q23 (MLL) abnormalities; adult acute myeloid leukemia with t(16;16)(p13;q22); ...
- Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00049179 - Active, not recruiting
adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
- Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
ClinicalTrials.gov Identifier: NCT00053131 - Active, not recruiting
recurrent adult acute myeloid leukemia; recurrent childhood acute myeloid leukemia; recurrent adult acute lymphoblastic leukemia; ...
- Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer
ClinicalTrials.gov Identifier: NCT00012376 - Active, not recruiting
adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia
ClinicalTrials.gov Identifier: NCT00008190 - Active, not recruiting
adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; childhood acute myeloid leukemia; ...
- Daunorubicin and Cytarabine With or Without Zosuquidar Trihydrochloride in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
ClinicalTrials.gov Identifier: NCT00046930 - Active, not recruiting
adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; Myelodysplastic Syndromes; secondary acute myeloid leukemia
- Combination Chemotherapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00005793 - Active, not recruiting
adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
- Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia
ClinicalTrials.gov Identifier: NCT00025545 - Active, not recruiting
adult acute lymphoblastic leukemia in remission; recurrent adult acute myeloid leukemia; acute undifferentiated leukemia; ...
- Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00005823 - Active, not recruiting
Acute Myeloid Leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; ...
- FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00042822 - Active, not recruiting
adult acute myeloid leukemia; adult non-Hodgkin's lymphoma; atypical chronic myeloid leukemia; ...
- VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies
ClinicalTrials.gov Identifier: NCT00070538 - Active, not recruiting
adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
- Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia
ClinicalTrials.gov Identifier: NCT00016159 - Active, not recruiting
adult acute myeloid leukemia in remission; childhood acute myeloid leukemia in remission; adult acute promyelocytic leukemia (M3); ...
- Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00004918 - Active, not recruiting
adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
- FR901228 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00062075 - Active, not recruiting
adult acute myeloid leukemia; secondary acute myeloid leukemia
- Daunorubicin and Cytarabine With or Without Oblimersen in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00085124 - Active, not recruiting
adult acute myeloid leukemia; secondary acute myeloid leukemia
- Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00005863 - Active, not recruiting
Acute Myeloid Leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; childhood acute monocytic leukemia; ...
- Tipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00101153 - Recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
- Amifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00003407 - Active, not recruiting
untreated adult acute myeloid leukemia; Drug Toxicity; secondary myelodysplastic syndrome; recurrent adult acute myeloid leukemia; ...
- Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00004245 - Active, not recruiting
adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
- Tretinoin, Cytarabine, and Daunorubicin With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003934 - Active, not recruiting
untreated adult acute myeloid leukemia; untreated childhood acute myeloid leukemia and other myeloid malignancies; ...
- Sorafenib in Treating Patients With Relapsed or Refractory Leukemia
ClinicalTrials.gov Identifier: NCT00131989 - Active, not recruiting
adult acute erythroid leukemia; adult acute lymphoblastic leukemia; adult acute monoblastic and acute monocytic leukemia; ...
- Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
ClinicalTrials.gov Identifier: NCT00101140 - Not yet recruiting
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
- Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00087204 - Completed
adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
- Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00045435 - Recruiting
adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
- Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia
ClinicalTrials.gov Identifier: NCT00030355 - Recruiting
recurrent childhood acute myeloid leukemia; recurrent adult acute myeloid leukemia; adult acute promyelocytic leukemia (M3); ...
- Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00003405 - Active, not recruiting
untreated adult acute myeloid leukemia; childhood acute megakaryocytic leukemia (M7); adult acute differentiated monocytic leukemia (M5b); ...
- Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant
ClinicalTrials.gov Identifier: NCT00107354 - Active, not recruiting
adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; ...
- Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00268242 - Recruiting
Adult Acute Erythroid Leukemia; Adult Acute Monoblastic and Acute Monocytic Leukemia; Adult Acute Myeloid Leukemia
- 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies
ClinicalTrials.gov Identifier: NCT00077181 - Active, not recruiting
adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Chronic Myelogenous Leukemia; secondary acute myeloid leukemia
- SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes
ClinicalTrials.gov Identifier: NCT00098826 - Recruiting
Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; acute undifferentiated leukemia; adult acute erythroid leukemia; ...
- Aminopterin in Treating Patients With Refractory Leukemia
ClinicalTrials.gov Identifier: NCT00003305 - Active, not recruiting
recurrent adult acute myeloid leukemia; recurrent childhood acute myeloid leukemia; recurrent adult acute lymphocytic leukemia; ...
- 17-N-Allylamino-17-Demethoxygeldanamycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes
ClinicalTrials.gov Identifier: NCT00098423 - Recruiting
Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; ...
- Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemias, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00217646 - Recruiting
Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; ...
- Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission
ClinicalTrials.gov Identifier: NCT00002609 - Active, not recruiting
childhood acute myeloid leukemia in remission; childhood acute promyelocytic leukemia (M3); adult acute myeloid leukemia in remission; ...
- Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00096148 - Completed
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; ...
- Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00101231 - Recruiting
adult acute erythroid leukemia; adult acute lymphoblastic leukemia; adult acute monoblastic and acute monocytic leukemia; ...
- Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia
ClinicalTrials.gov Identifier: NCT00002588 - Completed
adult acute myelomonocytic leukemia (M4); adult acute differentiated monocytic leukemia (M5b); recurrent adult acute lymphocytic leukemia; ...
- High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in Remission
ClinicalTrials.gov Identifier: NCT00002567 - Completed
adult acute myelomonocytic leukemia (M4); adult acute differentiated monocytic leukemia (M5b); ...
- Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00003230 - Active, not recruiting
untreated adult acute myeloid leukemia; untreated adult acute lymphocytic leukemia; recurrent adult acute myeloid leukemia; ...
- Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00003960 - Active, not recruiting
untreated adult acute myeloid leukemia; chronic phase chronic myelogenous leukemia; Previously Treated Myelodysplastic Syndrome; ...
- Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00003003 - Active, not recruiting
recurrent adult acute myeloid leukemia; secondary acute myeloid leukemia
- Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00003868 - Active, not recruiting
adult acute myeloid leukemia; childhood acute myeloid leukemia; secondary acute myeloid leukemia
- Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer
ClinicalTrials.gov Identifier: NCT00014495 - Recruiting
adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
- Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00006363 - Active, not recruiting
adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
- Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias
ClinicalTrials.gov Identifier: NCT00098436 - Active, not recruiting
adult acute lymphoblastic leukemia; adult acute myeloid leukemia; blastic phase chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; ...
- VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia
ClinicalTrials.gov Identifier: NCT00083187 - Active, not recruiting
adult acute myeloid leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; ...
- OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies
ClinicalTrials.gov Identifier: NCT00081055 - Active, not recruiting
adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
- CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase
ClinicalTrials.gov Identifier: NCT00084916 - Completed
adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
- Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission
ClinicalTrials.gov Identifier: NCT00070135 - Recruiting
adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
- Cilengitide in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00089388 - Completed
adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
- Biological Therapy in Treating Patients With Advanced Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00052520 - Recruiting
adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; ...
- MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00101179 - Active, not recruiting
adult acute myeloid leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes; secondary acute myeloid leukemia
- An Extension Study of the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia
ClinicalTrials.gov Identifier: NCT00171223 - Active, not recruiting
Philadelphia Positive Chronic Myeloid Leukemia in Accelerated Phase, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
- An Extension Study of the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia
ClinicalTrials.gov Identifier: NCT00171249 - Active, not recruiting
Philadelphia Positive Chronic Myeloid Leukemia in Accelerated Phase, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
- Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic Leukemia
ClinicalTrials.gov Identifier: NCT00008697 - Active, not recruiting
recurrent childhood acute myeloid leukemia; recurrent adult acute myeloid leukemia; adult acute promyelocytic leukemia (M3); ...
- Combination Chemotherapy and Thalidomide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes
ClinicalTrials.gov Identifier: NCT00053287 - Completed
adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
- Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00004056 - Active, not recruiting
childhood acute megakaryocytic leukemia (M7); untreated childhood acute myeloid leukemia; ...
- CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse
ClinicalTrials.gov Identifier: NCT00003673 - Active, not recruiting
recurrent adult acute myeloid leukemia
- Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin''s Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00275080 - Recruiting
Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; Adult Non-Hodgkin''s Lymphoma; Adult Solid Tumor; Chronic Myelogenous Leukemia
- Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00053014 - Completed
adult acute myeloid leukemia in remission; adult acute myeloid leukemia with t(8;21)(q22;q22); adult acute myeloid leukemia with t(16;16)(p13;q22); ...
- Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00003148 - Active, not recruiting
recurrent adult acute myeloid leukemia
- Phase II Study of Intensive Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantion in Patients With Chronic Myelogenous Leukemia or High Risk Acute Leukemia
ClinicalTrials.gov Identifier: NCT00004905 - Completed
adult acute myeloid leukemia in remission; chronic phase chronic myelogenous leukemia; recurrent adult acute myeloid leukemia; ...
- Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00002531 - Active, not recruiting
non-T, non-B adult acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia; B-cell adult acute lymphoblastic leukemia; ...
- Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00107523 - Active, not recruiting
adult acute myeloid leukemia
- Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplantation for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00093587 - Active, not recruiting
adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Graft Versus Host Disease; secondary acute myeloid leukemia
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Low-Dose Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00003875 - Recruiting
adult acute myeloid leukemia; childhood acute myeloid leukemia
- CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse
ClinicalTrials.gov Identifier: NCT00003131 - Active, not recruiting
recurrent adult acute myeloid leukemia
- Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia
ClinicalTrials.gov Identifier: NCT00002701 - Active, not recruiting
untreated adult acute myeloid leukemia; adult acute promyelocytic leukemia (M3)
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
